港股異動 | 睿見教育(6068.HK)直線拉昇漲近3% 2020/2021學年入學人數同比增長18.7%
格隆匯9月17日丨睿見教育(6068.HK)午後直線拉昇,現報3.18港元,漲2.91%,暫成交1637萬港元,最新總市值69億港元。睿見教育今日午間公佈,集團2020/2021學年開始時入學總人數為7.1362萬人,較2019/2020學年開始時入學總人數6.0116萬人增加1.1246萬人,增幅為18.7%。入學總人數增加,主要是由於惠州市光正實驗學校、雲浮市光明外國語學校、廣安光正實驗學校及巴中光正實驗學校的入學人數增加,順德光正實驗學校正式啟用以及包括集團自2020/2021學年起提供管理服務的其他第三方學校的入學人數。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.